EPA’s Draft Asbestos Evaluation Lists Unreasonable Risks, Legacy Uses Not Addressed
The EPA’s release of its Draft Risk Evaluation for Asbestos is a significant step in the Agency’s halting progress over more than 30 years to control the effects of one of the most carcinogenic substances in commercial use in the United States. The risk evaluation is a product of the 2016 amendments to the federal […]